Prediction of NODAT After Renal Transplantation
NCT00442988 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2007-03-05
Summary
A statistical analysis of the predictive value of OGTT and FPG testing executed as part of standard clinical practice after renal transplantation for the diagosis of new-onset diabetes mellitus after transplantation.
Conditions
- Renal Transplantation
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Principal Investigators
-
Dirk R Kuypers, MD, PhD · Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Completion
- 2005-10-31
Countries
- Belgium
Study Locations
More Related Trials
-
Estimating Glomerular Filtration Rate in Kidney Transplant Recipients
NCT05229939 ·Status: COMPLETED
-
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
NCT06025240 ·Status: RECRUITING
-
New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation
NCT01976689 ·Status: COMPLETED
-
Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants
NCT01982903 ·Status: UNKNOWN
-
Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure
NCT02455115 ·Status: COMPLETED ·Phase: NA
-
Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation
NCT06320730 ·Status: COMPLETED
-
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation
NCT02424227 ·Status: UNKNOWN
-
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
NCT01515605 ·Status: RECRUITING
-
Prospective Controlled Study of Posttransplant Diabetes
NCT00006331 ·Status: UNKNOWN
-
Short- and Long-Term Renal Outcomes Following Lung Transplantation
NCT03046277 ·Status: COMPLETED
-
Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period
NCT02849899 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of Predigraft in Kidney Transplant Patients
NCT04969757 ·Status: COMPLETED ·Phase: NA
-
Urinary Transglutaminase 2 as a Biomarker for Kidney Allograft Fibrosis
NCT03487861 ·Status: UNKNOWN
-
Comparing Glycaemic Benefits of Active Versus Passive Lifestyle Intervention in Kidney Allograft Recipients
NCT02233491 ·Status: COMPLETED ·Phase: NA
-
Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
NCT05866796 ·Status: RECRUITING
-
Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
NCT04702022 ·Status: RECRUITING ·Phase: NA
-
The Role of Biomarkers in the Early Detection of Acute Kidney Injury Induced by Liver Transplantation
NCT01333319 ·Status: COMPLETED
-
Deceased Donor Biomarkers and Recipient Outcomes
NCT01848249 ·Status: COMPLETED
-
Study in Detection cfDNA for the Early-stage Diagnosis of Acute Rejection Post-renal Transplantation
NCT03759535 ·Status: UNKNOWN
-
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation
NCT03866421 ·Status: TERMINATED
-
Reduced Calorie Diet Intervention in Kidney Transplant Recipients
NCT00994838 ·Status: COMPLETED ·Phase: PHASE2
-
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
NCT01289717 ·Status: COMPLETED
-
Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients
NCT03765203 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of a Clinical Risk Prediction Model for Early Acute Kidney Injury Within 48 Hours After Liver Transplantation
NCT06750770 ·Status: COMPLETED
-
Measuring Kidney Function in Kidney Transplantation
NCT00212979 ·Status: COMPLETED